Owner Duke University

Inventors Toone, Eric J; Stamler, Jonathan S; Zenn, Michael R

Agent Cullen & Co

Pub. Number AU-B-2002365036

PCT Number PCT/US02/36138

PCT Pub. Number WO2003/049593

Priority 60/336,175 06.12.01 US

Filing date 2 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 21 September 2006

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61B 1/00 (2006.01) Diagnosis

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/04 (2006.01) - Nitro compounds

A61K 31/095 (2006.01) - Sulfur, selenium or tellurium compounds, e.g. thiols

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/724 (2006.01)

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/04 (2006.01) Medicinal preparations containing inorganic active ingredients - Sulfur, selenium or tellurium

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups